Out of all of your investments, which one do you feel has the most potential to run over the next 12 months?
Thanks for the tips!
If it is Titan, please say that, but maybe list one more?
IMSC, the 'bomb sniffer' equipment company. This company has the best product out there and is on the verge of having its equipment approved by the TSA. The company has two products, one that can be used to screen people and one that can be used to screen cargo. The product does not use
radioactive material and it operates much, much more efficiently than competitive offerings.
The product can detect bomb materials, as well as drugs. It is currently being sold all over the world and is receiving lots of 'repeat' orders, always a good thing.
It is possible that all passenger screening could eventually use a metal detector plus the IMSC equipment.
This is a pink sheet stock with a terrible balance sheet but with very large potential. It is selling today for around $1.15 per share.
Well you know of TTNP and NAVB, but my other spec investment is INO (Inovio). They have 2 Phase II vaccines that will have data out later in 2013. They are HPV, HEP C and Lukemia.....I believe it can run to ~$1.50+. They have many deep pocketed partners to include a large pharma, a research university in the UK, and the US Govt. NIADS for the HIV study. Oh and several FLU vaccines.........
Sentiment: Strong Buy
Nowak, if you consider "pennies" you should take a strong look at CTSO. Smart management with impeccable credentials, strong moral character, already received approval in the E.U. with sales starting a few months ago, and endorsed by U.S. military grants. additionally, the company will probably uplist in 2013, as well. Good luck. K.C.
By the way, Dr. Chan stated that a shareholder update (CTSO) will be provided early in January, 2013. He doesn't put out "fluff" press releases, and is extremely conservative with shareholder money. For a good intro. to the company, check out ping_pow_princess' post on the Yahoo Message Board for CTSO under the heading "2012 Recap." Good luck. K.C.
DVAX got mixed results from their ODAC and price tanked. Great efficacy, mixed votes on safety. If FDA decides to approve it, it may double from current price. You vote!
CLDX, if it finds a partner for at least 1 drug. May be getting ready to do a stock offering before that happens - good time to start a position.
AEZS also down from perifosine results with KERX for solid tumors, gone up the past few days. Many believe perif may do well with blood tumors.
Those are my low priced ones. Many more awaiting partners, buyouts, clinical trial results. Just hoping for at least 20% gain for most of them in 2013.
OK, I'll add LPTN to your study list. Long term play for AMD.